Ionis Pharmaceuticals Long Term Debt 2010-2024 | IONS

Ionis Pharmaceuticals long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Ionis Pharmaceuticals Annual Long Term Debt
(Millions of US $)
2024 $1,245
2023 $1,230
2022 $1,183
2021 $1,228
2020 $624
2019 $786
2018 $633
2017 $606
2016 $516
2015 $524
2014 $383
2013 $157
2012 $151
2011 $146
2010 $139
2009 $137
Ionis Pharmaceuticals Quarterly Long Term Debt
(Millions of US $)
2024-12-31 $1,245
2024-09-30 $1,234
2024-06-30 $1,232
2024-03-31 $1,231
2023-12-31 $1,230
2023-09-30 $1,279
2023-06-30 $1,315
2023-03-31 $1,177
2022-12-31 $1,183
2022-09-30 $1,250
2022-06-30 $1,248
2022-03-31 $1,248
2021-12-31 $1,228
2021-09-30 $1,242
2021-06-30 $1,241
2021-03-31 $871
2020-12-31 $624
2020-09-30 $815
2020-06-30 $804
2020-03-31 $795
2019-12-31 $786
2019-09-30 $656
2019-06-30 $663
2019-03-31 $654
2018-12-31 $633
2018-09-30 $624
2018-06-30 $625
2018-03-31 $614
2017-12-31 $606
2017-09-30 $598
2017-06-30 $532
2017-03-31 $523
2016-12-31 $516
2016-09-30 $423
2016-06-30 $404
2016-03-31 $398
2015-12-31 $524
2015-09-30 $399
2015-06-30 $394
2015-03-31 $388
2014-12-31 $383
2014-09-30 $159
2014-06-30 $158
2014-03-31 $158
2013-12-31 $157
2013-09-30 $155
2013-06-30 $154
2013-03-31 $152
2012-12-31 $151
2012-09-30 $151
2012-06-30 $156
2012-03-31 $147
2011-12-31 $146
2011-09-30 $144
2011-06-30 $143
2011-03-31 $140
2010-12-31 $139
2010-09-30 $135
2010-06-30 $135
2010-03-31 $131
2009-12-31 $137
2009-09-30 $136
2009-06-30 $132
2009-03-31 $131
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.796B $0.705B
Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $74.838B 29.53
Zoetis (ZTS) United States $73.729B 27.81
Takeda Pharmaceutical (TAK) Japan $47.315B 10.47
Daiichi Sankyo, - (DSNKY) Japan $45.571B 27.77
Sandoz Group AG (SDZNY) Switzerland $18.445B 0.00
Merck (MKKGY) Germany $17.719B 14.66
Astellas Pharma (ALPMY) Japan $17.481B 12.39
Summit Therapeutics (SMMT) United States $14.230B 0.00
United Therapeutics (UTHR) United States $13.845B 12.53
Shionogi (SGIOY) Japan $12.760B 12.78
Corcept Therapeutics (CORT) United States $12.051B 92.11
Neurocrine Biosciences (NBIX) United States $11.027B 33.62
IPSEN (IPSEY) France $9.797B 0.00
Orion OYJ (ORINY) Finland $8.460B 23.98
Madrigal Pharmaceuticals (MDGL) United States $7.314B 0.00
Stevanato Group S.p.A (STVN) Italy $6.184B 39.27
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.254B 10.76
Grifols, S.A (GRFS) Spain $4.889B 0.00
Soleno Therapeutics (SLNO) United States $3.277B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.121B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.945B 12.01
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.598B 16.11
NewAmsterdam Pharma (NAMS) Netherlands $2.248B 0.00
Hypermarcas (HYPMY) Brazil $2.131B 8.41
Recursion Pharmaceuticals (RXRX) United States $2.127B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.915B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.567B 0.00
Guardian Pharmacy Services (GRDN) United States $1.346B 0.00
Indivior (INDV) United States $1.314B 5.71
ARS Pharmaceuticals (SPRY) United States $1.234B 157.25
Evotec AG (EVO) Germany $1.184B 0.00
Dyne Therapeutics (DYN) United States $1.183B 0.00
Ardelyx (ARDX) United States $1.170B 0.00
Ocular Therapeutix (OCUL) United States $1.166B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.104B 44.67
Enliven Therapeutics (ELVN) United States $0.964B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.09
Harrow (HROW) United States $0.948B 0.00
Xeris Biopharma Holdings (XERS) United States $0.845B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.757B 0.00
Bioventus (BVS) United States $0.750B 19.47
Xencor (XNCR) United States $0.750B 0.00
Cronos Group (CRON) Canada $0.692B 0.00
KalVista Pharmaceuticals (KALV) United States $0.574B 0.00
Organogenesis (ORGO) United States $0.548B 0.00
USANA Health Sciences (USNA) United States $0.510B 10.37
Savara (SVRA) United States $0.478B 0.00
Elite Pharmaceuticals (ELTP) United States $0.465B 0.00
Akebia Therapeutics (AKBA) United States $0.454B 0.00
Relay Therapeutics (RLAY) United States $0.444B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.442B 0.00
Verve Therapeutics (VERV) United States $0.406B 0.00
Zevra Therapeutics (ZVRA) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.391B 6.68
Tourmaline Bio (TRML) United States $0.391B 0.00
Altimmune (ALT) United States $0.385B 0.00
Oruka Therapeutics (ORKA) United States $0.384B 0.00
Aldeyra Therapeutics (ALDX) United States $0.343B 0.00
Heron Therapeutics (HRTX) United States $0.335B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.321B 19.14
Amylyx Pharmaceuticals (AMLX) United States $0.314B 0.00
OmniAb (OABI) United States $0.293B 0.00
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Esperion Therapeutics (ESPR) United States $0.285B 36.00
CytoDyn (CYDY) United States $0.283B 0.00
ProKidney (PROK) United States $0.256B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.235B 73.50
Nature's Sunshine Products (NATR) United States $0.232B 27.28
Wellgistics Health (WGRX) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.213B 0.00
Profound Medical (PROF) Canada $0.175B 0.00
Nanobiotix S.A (NBTX) France $0.169B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Korro Bio (KRRO) United States $0.163B 0.00
Inhibikase Therapeutics (IKT) United States $0.163B 0.00
Lyell Immunopharma (LYEL) United States $0.159B 0.00
Protara Therapeutics (TARA) United States $0.157B 0.00
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Larimar Therapeutics (LRMR) United States $0.138B 0.00
Nektar Therapeutics (NKTR) United States $0.127B 0.00
Journey Medical (DERM) United States $0.123B 0.00
Champions Oncology (CSBR) United States $0.120B 19.73
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
Regulus Therapeutics (RGLS) United States $0.116B 0.00
Lexeo Therapeutics (LXEO) United States $0.115B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.115B 0.00
Telomir Pharmaceuticals (TELO) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
OptiNose (OPTN) United States $0.092B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Cardiol Therapeutics (CRDL) Canada $0.080B 0.00
Galectin Therapeutics (GALT) United States $0.077B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Cassava Sciences (SAVA) United States $0.072B 0.00
ESSA Pharma (EPIX) Canada $0.070B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.069B 0.00
Nutriband (NTRB) United States $0.068B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Pyxis Oncology (PYXS) United States $0.060B 0.00
Unicycive Therapeutics (UNCY) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Context Therapeutics (CNTX) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
AleAnna (ANNA) United States $0.052B 0.00
Metagenomi (MGX) United States $0.051B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Dominari Holdings (DOMH) United States $0.044B 0.00
Iterum Therapeutics (ITRM) Ireland $0.043B 0.00
Prelude Therapeutics (PRLD) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.041B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Surrozen (SRZN) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Tempest Therapeutics (TPST) United States $0.034B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
Karyopharm Therapeutics (KPTI) United States $0.031B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
DURECT (DRRX) United States $0.025B 0.00
VYNE Therapeutics (VYNE) United States $0.024B 0.00
Mural Oncology (MURA) Ireland $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
BioVie (BIVI) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 6.90
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 8.95
TherapeuticsMD (TXMD) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Cosmos Health (COSM) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
ProPhase Labs (PRPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 2.89
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Alaunos Therapeutics (TCRT) United States $0.002B 0.00
CERo Therapeutics Holdings (CERO) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
TransCode Therapeutics (RNAZ) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00